CCN2 and Myocardial fibrosis: Other researchers verified in vivo and in vitro that trimetazidine could effectively inhibit myocardial fibrosis through nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-reactive oxygen species (ROS)-connective tissue growth factor (CTGF) signaling pathway [28].